8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 2, 2016

Commission File Number: 0-24260

 

 

 

LOGO

Amedisys, Inc.

(Exact name of registrant as specified in charter)

 

 

 

Delaware   11-3131700
(State or other jurisdiction   (IRS Employer
of incorporation or organization)   Identification No.)

3854 American Way, Suite A, Baton Rouge, LA 70816

(Address of principal executive offices, including zip code)

(225) 292-2031 or (800) 467-2662

(Registrant’s telephone number, including area code)

5959 S. Sherwood Forest Blvd., Baton Rouge, LA 70816

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

Amedisys, Inc. (the “Company”) held its annual meeting of stockholders on Thursday, June 2, 2016. At the annual meeting, the Company’s stockholders voted on three proposals. A brief description of and tabulation of votes for each proposal are set forth below.

Proposal 1. The Company’s stockholders elected the following ten directors for a term of one year. There were 1,777,311 broker non-votes with respect to the proposal.

 

Nominee

   For      Withheld  

Linda J. Hall, PhD

     29,112,781         132,473   

Julie D. Klapstein

     29,113,410         131,844   

Paul B. Kusserow

     29,081,934         163,320   

Ronald A. LaBorde

     27,810,323         1,434,931   

Richard A. Lechleiter

     29,110,319         134,935   

Jake L. Netterville

     29,052,463         192,791   

Bruce D. Perkins

     29,111,082         134,172   

Jeffrey A. Rideout, MD

     29,112,760         132,494   

Donald A. Washburn

     28,782,630         462,624   

Nathaniel M. Zilkha

     23,586,989         5,658,265   

Proposal 2. The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accountants for the fiscal year ending December 31, 2016. There were no broker non-votes with respect to the proposal.

 

For

  

Against

    

Abstain

 

30,831,740

     180,716         10,109   

Proposal 3. The Company’s stockholders approved, on an advisory (non-binding) basis, the compensation paid to the Company’s named executive officers. There were 1,777,311 broker non-votes with respect to the proposal.

 

For

  

Against

    

Abstain

 

26,670,433

     2,540,608         34,213   


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMEDISYS, INC.

By:  

/s/ Paul B. Kusserow

Paul B. Kusserow

President and Chief Executive Officer

DATE: June 3, 2016